Gross proceeds of approximately $2.4 million from sale of PAVmed securities priced at-the-market and Veris common stock priced at a $35 million pre-money valuation PAVmed Inc. is a diversified ...

Shareholders are encouraged to consult with their tax advisors as to the specific tax treatment of Veris Residential, Inc. distributions. About Veris Residential, Inc. Veris Residential ...

Truist raised the firm’s price target on Veris Residential (VRE) to $17 from $16 and keeps a Hold rating on the shares. The firm updated apartment real estate investment trust models to reflect ...

Truist analyst Michael Lewis raised the firm’s price target on Veris Residential (VRE) to $17 from $16 and keeps a Hold rating on the shares as part of a broader research note on REITs.

NYSE:VRE opened at $16.21 on Monday. Veris Residential has a 1-year low of $13.84 and a 1-year high of $18.85. The firm has a market capitalization of $1.51 billion, a price-to-earnings ratio of ...

NYSE:VRE opened at $16.89 on Wednesday. The stock’s 50 day moving average price is $16.06 and its 200 day moving average price is $16.97. Veris Residential has a 52 week low of $13.84 and a 52 ...

In trading on Tuesday, shares of Veris Residential Inc (Symbol: VRE) crossed above their 200 day moving average of $16.44, changing hands as high as $16.50 per share. Veris Residential Inc shares ...